Share your videos with the world

Sign Up | Log In | Help  

   
 
Related Tags: meijer  drugs  prescription  health  healthcare  expired  unused  pharmacy  pills  safety  multivu  8497051  drugs  cost  medication  medical  health  money  prices  saving  multivu  8478051  allergy  medications  health  sanofi  relief  medical  adam  savage  treatment  multivu  8255452  health  healthcare  medication  medical  technology  bd  hospitals  costs  multivu  8198551  kids  safety  medicine  health  fever  flu  children  spoon  dose  multivu  8171651  medicine  family  safety  health  pharmaceuticals  teeth  children  cold  probiotics  multivu  8134881  opioid  overdoses  drugs  aac  help  awareness  addiction  recovery  multivu  8130951  blink  health  health  healthcare  type  2  diabetes  treatment  medication  money  multivu  8117451  csl  behring  global  biotherapeutics  medicine  study  research  fda  healthcare  health  multivu  8056151  mobile  app  lung  cancer  health  technology  phone  healthcare  treatment  multivu  7865551  livanova  medical  technology  therapy  health  treatment  drug  vns  epilepsy  multivu  7966451  science  abbott  technology  health  treatment  healthcare  medication  new  breakthrough  multivu  7962251 
Search // medication
Results 1-12 of 54 for ' medication ' (0 seconds)
Express Scripts clinical innovations saved its clients $45 billion in 2018 and delivered a 25-year record low drug trend of just 0.4 percent across employer-sponsored plans, according to data released today in its annual Drug Trend Report, an authoritative analysis of drug spending in the U.S. Express Scripts’ solutions for driving lower drug prices and fostering the use of lower-net-cost treatments are making medication more accessible for beneficiaries. Unit drug costs decreased in 2018 for employer-sponsored and Medicare plans, while utilization of medications rose. To view the multimedia release go to: https://www.multivu.com/players/English/8478051-express-scripts-2018-drug-trend-report/
Categories // Miscellaneous 
Added: 102 days ago by MultiVuVideos
Runtime: 1m5s | Views: 3 | Comments: 0
Not yet rated
 

 

 

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, will launch its latest advancement in comprehensive medication management, BD HealthSight™ platform for enterprise medication management, which offers a unique combination of connective technologies, analytics and expert services at this year's American Society of Health-System Pharmacists (ASHP) 2017 Midyear Meeting being held in Orlando from Dec. 3-7. With direct medical costs associated with medication errors reaching $21 billion worldwide, innovative strategies must be developed to address the grand health challenges associated with medication management. BD has been evolving its focus to re-invent medication management with integration of the company’s technologies, analytics and expert services that aim to close the communication gaps across disparate solutions. The BD HealthSight platform connects systems and processes to help hospitals and health systems drive a safer, more efficient medication management process. To view the multimedia release go to: https://www.multivu.com/players/English/8198551-bd-healthsight-platform-ashp-2017/
Categories // Miscellaneous 
Added: 549 days ago by MultiVuVideos
Runtime: 2m24s | Views: 5 | Comments: 2
Not yet rated
 

 

 

Mark your calendars now – those leftover OTC and prescriptions in your medicine cabinet have got to go! Chances are, if you open your medicine cabinet, you’ll find some some leftover medication that “might come in handy someday.” The reality is, those medications may have expired and are either ineffective or may cause more harm than you know. With cold and flu season upon us, it’s a great time to purge the medicine cabinet. Better to prepare now than scramble when you are sick. Clean out clutter and stock up on the staples!
Categories // Miscellaneous 
Added: 583 days ago by MultiVuVideos
Runtime: 2m30s | Views: 2 | Comments: 2
Not yet rated
 

 

 

Each day in the U.S. 91 people die from an opioid-related overdose, and the numbers are increasing. In observance of International Overdose Awareness Day on August 31, American Addiction Centers (AAC) and Recovery Brands are launching a nationwide awareness campaign on how to prevent deaths from opioid overdoses. The campaign features shareable online resources, including an animation video about how an overdose impacts a body, an infographic about how to administer overdose medication, and powerful videos of survivors sharing the life-saving lessons they learned during their darkest hours. “This is a meaningful endeavor as we partner with our parent company, AAC, in order to present several life-saving resources for people impacted by addiction,” said Ruchi Dhami, director of market insights and development at Recovery Brands, a provider of digital addiction treatment resources. “Since such a large amount of individuals look for information online about addiction and treatment, we wanted to ensure comprehensive education surrounding opioid overdoses existed and is easily accessible for individuals and families impacted by addiction.” To view the multimedia release go to: https://www.multivu.com/players/English/8130951-american-addiction-centers-opioid-overdose/
Categories // Miscellaneous 
Added: 641 days ago by MultiVuVideos
Runtime: 2m32s | Views: 7 | Comments: 1
Not yet rated
 

 

 

Blink Health, America’s leading prescription drug savings platform, today launched a program to help #TreatType2 diabetes by committing to give away $10 million worth of medication to patients with type-2 diabetes. People living with diabetes who create an account on Blink Health’s website or free mobile app, starting today, will receive a free, one-year supply of the three most commonly prescribed generic medications for type-2 diabetes: metformin, glipizide and pioglitazone. The program will also cover these three medications for existing Blink Health patients who use them. To view the multimedia release go to: https://www.multivu.com/players/English/8117451-blink-health-type-2-diabetes-medications/
Categories // Miscellaneous 
Added: 710 days ago by MultiVuVideos
Runtime: 0m15s | Views: 5 | Comments: 0
Not yet rated
 

 

 

Global biotherapeutics leader CSL Behring today announced that results were published in the New England Journal of Medicine (NEJM) from the COMPACT study, a pivotal Phase III study evaluating the safety and efficacy of CSL830 (a novel, investigational, self-administered, subcutaneous C1-Esterase Inhibitor [C1-INH] Human replacement therapy) for the prevention of HAE attacks. The study met its primary efficacy endpoint, significantly reducing the time-normalized number of HAE attacks. In addition, the study met its secondary endpoints, including the responder rate (patients who had at least a 50% reduction in their attack rate) and the number of rescue medication uses. If approved by the FDA, CSL830 would be the first and only subcutaneous preventative therapy for HAE. To view the multimedia release go to: https://www.multivu.com/players/English/8056151-csl-behring-subcutaneous-c1-esterase-inhibitor-hae-patients/
Categories // Miscellaneous 
Added: 787 days ago by MultiVuVideos
Runtime: 2m41s | Views: 5 | Comments: 0
Not yet rated
 

 

 

Don’t trust us, trust Science: Abbott is among the best science-based companies to work for in the world. For the 13th consecutive year, the journal Science today recognized Abbott on its Top Employers list, evaluated on 23 characteristics including financial strength, easy adaptation to change and a having a research-driven environment. ”Abbott is unique in that we’ve been adding to our reservoir of scientific knowledge for 128 years,“ said John Frels, Ph.D., chair of Abbott’s Scientific Governing Board, which oversees the company’s senior scientific career track. ”We strive to bring in the best and brightest scientists and engineers to work on some of the biggest problems in healthcare today. This helps us to create new, breakthrough innovations that change people’s lives.“ To view the multimedia release go to: http://www.multivu.com/players/English/7962251-science-names-abbott-2016-top-employer/
Categories // Miscellaneous 
Added: 933 days ago by MultiVuVideos
Runtime: 0m45s | Views: 65 | Comments: 0
Not yet rated
 

 

 

The following statement is being issued by Branstetter, Stranch & Jennings, PLLC regarding In re Prograf Antitrust Litigation. A lawsuit is currently pending claiming that Astellas Pharma US, Inc. (“Astellas” or “Defendant”) violated state antitrust, unfair competition, consumer protection, and unjust enrichment laws of certain states by delaying the availability of a less expensive generic version of the immunosuppressant prescription drug Prograf® (known as tacrolimus). Plaintiffs allege that Defendant’s conduct caused some consumers and third party payors to pay too much for Prograf in certain states from September 3, 2008 to December 31, 2010 (also referred to as the “Class Damage Period”). This lawsuit does not claim that Prograf is unsafe or ineffective. Astellas denies any wrongdoing. To view the multimedia release go to: http://www.multivu.com/players/English/7933851-prograf-antitrust-class-action-settlement/
Categories // Miscellaneous 
Added: 936 days ago by MultiVuVideos
Runtime: 0m30s | Views: 58 | Comments: 0
Not yet rated
 

 

 

On World Mental Health Day, Janssen has announced the results of a pan-European research project: ‘Talking About Treatment in Schizophrenia: A Patient and Carer Survey’. The survey of 166 adults living with schizophrenia and 468 carers was conducted by the independent market research agency, Fieldwork International (part of Ipsos MORI), and explored awareness, feelings and preferences regarding treatment. The survey, conducted across 12 countries in Europe (Austria, Belgium, Denmark, France, Germany, Italy, Netherlands, Russia, Spain, Sweden, Switzerland and the UK), highlighted key factors affecting the peace of mind for carers, such as the impact of the condition on day‑to-day life, potential relapse/hospitalisation and getting support beyond medication. 94% stated they reminded the person they care for to take their medication and for 49% this happens often. To view the multimedia release go to: http://www.multivu.com/players/uk/7947151-janssen-survey-carers-adults-schizophrenia/
Categories // Miscellaneous 
Added: 951 days ago by MultiVuVideos
Runtime: 4m15s | Views: 84 | Comments: 0
Not yet rated
 

 

 

A new survey from the Gout & Uric Acid Education Society (GUAES) finds many Americans with gout may be placing too much emphasis on diet when it comes to managing the disease and controlling painful flares. Of all the steps taken to manage gout, respondents cited changing their diet by eliminating or reducing consumption of certain foods as their top step taken (50 percent)—even ahead of taking medications to lower their uric acid levels (40 percent) and maintaining an overall healthy fitness level (33 percent). Furthermore, nearly one in three with gout incorrectly believes that the disease can be completely avoided by eliminating certain foods; and more than one in four said they would not take medications if they were making dietary changes. “Physicians all too often see patients who believe they can successfully manage their gout with diet alone,” said N. Lawrence Edwards, M.D., a rheumatologist and GUAES chairman. “But even with extremely rigid diet restrictions, most gout patients will only be able to lower their uric acid levels slightly—not nearly enough to achieve a healthy level to control flares and reduce risk for long-term damage.” To view the multimedia release go to: http://www.multivu.com/players/English/7835451-guaes-diet-survey/
Categories // Miscellaneous 
Added: 1094 days ago by MultiVuVideos
Runtime: 3m56s | Views: 187 | Comments: 0
Not yet rated
 

 

 

CVS Health (NYSE:CVS), the nation’s largest pharmacy innovation company, today announced Be The First, a five-year $50 million initiative to help deliver the nation’s first tobacco-free generation. Through this initiative, which is funded through CVS Health and the CVS Health Foundation, the company is extending its commitment to help people lead tobacco-free lives. Recognizing that tobacco use is the leading preventable cause of disease and death in the United States and that youth use of some tobacco products is on the rise, Be The First comprises comprehensive education, advocacy, tobacco control and healthy behavior programming in partnership with organizations uniquely positioned to tackle this public health challenge. “We are at a critical moment in our nation’s efforts to end the epidemic of tobacco use that continues to kill more people than any other preventable cause of death, and threatens the health and well-being of our next generation,” said Troyen A. Brennan, M.D., M.P.H., and Chief Medical Officer for CVS Health. “Ensuring our youth stay tobacco-free requires increased education and awareness of healthy behaviors. We’re partnering with experts across the public health community who have established best practices to help prevent tobacco use. And, by establishing more public-private partnerships to implement these strategies more aggressively, we can help increase the number of people leading tobacco-free lives and move us one step closer to delivering the first tobacco-free generation.” To view the multimedia release go to: http://www.multivu.com/players/English/7775151-cvs-health-be-the-first/
Categories // Miscellaneous 
Added: 1165 days ago by MultiVuVideos
Runtime: 1m10s | Views: 216 | Comments: 0
Not yet rated
 

 

 

More than 15 percent of reproductive-aged women have filled a prescription for an antidepressant medication during the years 2008–2013, according to a new analysis published today in the Centers for Disease Control and Prevention (CDC)’s Morbidity and Mortality Weekly Report (MMWR). January is National Birth Defects Prevention Month and the CDC is working with the March of Dimes to raise awareness about the use of antidepressant medications by women of reproductive age, and what women should know and do for their own health and that of their babies. There is conflicting evidence about the potential link between some antidepressants and certain birth defects. Some commonly used antidepressants are sertraline (Zoloft), bupropion (Wellbutrin, Zyban), and citalopram (Celexa). To view the multimedia release go to: http://www.multivu.com/players/English/7709851-march-of-dimes-antidepressant-pregnancy-study/
Categories // Miscellaneous 
Added: 1207 days ago by MultiVuVideos
Runtime: 1m31s | Views: 263 | Comments: 0
Not yet rated
 

 

 

Page 1 of 5  |  Go to page    Next» LAST»»



About Us   |   Help  |   Advertise on ClipMoon   |   Terms of Use   |   Privacy Policy   |   Copyright   |   Contact   |   Link us   |   RSS 
Copyright © 2007-2019 ClipMoon.com. All rights reserved.